A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Translational Research Laboratory Core Bookmark and Share

Translational Research Laboratory Core

The Translational Research Laboratory Core at City of Hope is under the direct supervision of  Yen Yun, M.D., Ph.D., Dr. & Mrs. Allen Y. Chao Chair in Developmental Cancer Therapeutics and Professor and Chair of the Department of Molecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Prices and availability vary - please contact us at 626-256-HOPE (4673) for more information. If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Translational Research Laboratory Core

Translational Research Laboratory Core

The Translational Research Laboratory Core at City of Hope is under the direct supervision of  Yen Yun, M.D., Ph.D., Dr. & Mrs. Allen Y. Chao Chair in Developmental Cancer Therapeutics and Professor and Chair of the Department of Molecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Pricing

Prices and availability vary - please contact us at 626-256-HOPE (4673) for more information. If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Translational Research Team

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media
 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 


NEWS & UPDATES
  • Valentine’s Day is synonymous with dinner reservations, red roses, heart-shaped boxes of chocolates and — more often than not — unrealistically high expectations. Managing those expectations is great advice for all couples on Feb. 14 — and is especially important for couples confronting a cancer diagnosis. Focu...
  • With measles, what starts at a theme park in California definitely doesn’t stay at a theme park in California. Since the beginning of the current measles outbreak – traced to an initial exposure at Disneyland or Disney California Adventure during December – more than 100 people have been diagnosed with a diseas...
  • Even the most loving and secure relationship can be rattled by a life-threatening illness. When a woman is diagnosed with breast cancer, research shows one of the most important factors in helping her cope is having a supportive partner. But that partner can struggle with knowing what to say or how to best supp...
  • It’s been more than a century since Nobel Laureate Paul Ehrlich popularized the idea of a “magic bullet” targeting disease. Cancer researchers ever since have remained in hot pursuit of targeted therapies that home in on cancer cells while leaving normal cells unaffected. Linda Malkas, Ph.D., associate chair of...
  • Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD). Now, one researcher may have found a better way to control that threat. GVHD res...
  • Michele Dahlstein, a 50-year-old breast cancer survivor from Upland, California, celebrated her last day of chemotherapy on Dec. 30. She shares her story in her own words: I was diagnosed with breast cancer (invasive ductal carcinoma stage 2) on Aug. 11, 2014, after my yearly mammogram at City of Hope’s W...
  • The treatment of urologic cancers, including bladder cancer, is rapidly evolving. Here, urologic oncologic surgeon and kidney stone specialist Donald Hannoun, M.D., an assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope | Antelope Valley, explains the changes in hi...
  • A woman confronting metastatic breast cancer faces challenges that, at the outset, seem overwhelming. Research tells us these patients are especially vulnerable to anxiety, depression, hopelessness and other sources of distress. At the same time, they are asked to make complicated choices about their medical ca...
  • California health officials are opting to be safe rather than sorry when it comes to e-cigarettes. The increasingly popular devices are a public health threat, according to a California Department of Health report released Jan. 28. The department is seeking statewide regulation of e-cigarettes, saying they  emi...
  • “Not beyond us.” On World Cancer Day, researchers and caregivers around the globe are embracing this refrain. Specifically, the day calls for action to support healthier lifestyles, early cancer detection, quality of life and access to care. In a time of impressive scientific discovery and narrowing...
  • With more advanced cancer treatments and therapies saving lives every day, it’s safe to say cancer is “Not beyond us,” the official tagline for this year’s World Cancer Day. This year’s World Cancer Day observance takes place on Wednesday, Feb. 4, and focuses on cancer prevention, detection an...
  • Does our environment increase our risk of cancer? What about plastic bottles, radiation, chemicals, soy products …? Do they cause cancer? With so many cancer fears, rumors and downright urban legends circulating among our friends and colleagues, not to mention in the media and blogosphere, why not ask the...
  • With this week’s World Cancer Day challenging us to think about cancer on a global scale, we should also keep in mind that daily choices affect cancer risk on an individual scale. Simply put, lifestyle changes and everyday actions can reduce your cancer risk and perhaps prevent some cancers. According to ...
  • If you haven’t heard the term “precision medicine,” you will. If you don’t have an opinion about access to it, you will. On Friday, President Barack Obama unveiled details of the Precision Medicine Initiative, an effort intended to accelerate cancer research in a powerful way, giving doctors new knowledge and n...
  • The lack of a practical way to produce and store enough stem cells for larger-scale therapies and clinical trials is creating a bottleneck in stem cell research. A new grant to City of Hope from the California Institute for Regenerative Medicine (CIRM) will help solve that problem. The $899,728 grant, awarded T...